Clinical Trial Update: A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial NCT00817817 evaluated two mometasone dry powder inhalers for efficacy and safety in asthma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mometasone Dry Powder Inhaler (Formulation A) (mometasone furoate)
• Mometasone Dry Powder Inhaler (Formulation B) (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED